Top US Drug Company: Game-Changing COVID Pill Synthesized, Trials Show a Profound Effect

One of the country’s largest pharmaceutical companies plans to seek emergency use authorization for an antiviral COVID-19 therapy that can be taken orally from home, which reportedly reduces the risk of hospitalization by 50 percent.

If approved and effective, the treatment could put those with infections at reduced risk for complications. Such a drug could also disarm public officials who continue to use the coronavirus pandemic to bolster the size and reach of government.

Pharmaceutical giant Merck & Co. joined up with Ridgeback Biotherapeutics LP. The two companies say they have come up with an oral antiviral medicine called molnupiravir.

(Excerpt) Read more at Western Journal

SHARE:

Leave a Comment

Your email address will not be published. Required fields are marked *

CommentLuv badge

This site uses Akismet to reduce spam. Learn how your comment data is processed.